Sample Size Planning – Experience from Reviewing Psychiatric Clinical Trials
*Peiling Yang, US FDA Keywords: Sample Size In this talk, I will summarize the sample size planning from completed trials and explore the differences in this aspect between positive and negative trials using information collected from the FDA archived database. I will also provide an overview of sample size planning that was recently proposed in ongoing trials and discuss the pros and cons.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC